These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 20605840)

  • 1. Is fetuin-A a mortality risk factor in dialysis patients or a mere risk marker? A Mendelian randomization approach.
    Verduijn M; Prein RA; Stenvinkel P; Carrero JJ; le Cessie S; Witasp A; Nordfors L; Krediet RT; Boeschoten EW; Dekker FW
    Nephrol Dial Transplant; 2011 Jan; 26(1):239-45. PubMed ID: 20605840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene polymorphisms and serum alpha-2-Heremans-Schmid levels in Italian haemodialysis patients.
    Cozzolino M; Biondi ML; Galassi A; Gallieni M; d'Eril GV; Brancaccio D
    Am J Nephrol; 2007; 27(6):639-42. PubMed ID: 17851232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of AHSG gene polymorphisms with fetuin-A plasma levels and cardiovascular diseases in the EPIC-Potsdam study.
    Fisher E; Stefan N; Saar K; Drogan D; Schulze MB; Fritsche A; Joost HG; Häring HU; Hubner N; Boeing H; Weikert C
    Circ Cardiovasc Genet; 2009 Dec; 2(6):607-13. PubMed ID: 20031641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human serum fetuin A/alpha2HS-glycoprotein level is associated with long-term survival in patients with alcoholic liver cirrhosis, comparison with the Child-Pugh and MELD scores.
    Kalabay L; Gráf L; Vörös K; Jakab L; Benko Z; Telegdy L; Fekete B; Prohászka Z; Füst G
    BMC Gastroenterol; 2007 Mar; 7():15. PubMed ID: 17394649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic association of alpha2-Heremans-Schmid glycoprotein polymorphism with late-onset Alzheimer's disease in Italians.
    Geroldi D; Minoretti P; Bianchi M; Di Vito C; Reino M; Bertona M; Emanuele E
    Neurosci Lett; 2005 Oct; 386(3):176-8. PubMed ID: 16002217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study.
    Brandenburg VM; Schlieper G; Heussen N; Holzmann S; Busch B; Evenepoel P; Vanholder R; Meijers B; Meert N; Fassbender WJ; Floege J; Jahnen-Dechent W; Ketteler M
    Nephrol Dial Transplant; 2010 Aug; 25(8):2672-9. PubMed ID: 20172849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients.
    Wang AY; Woo J; Lam CW; Wang M; Chan IH; Gao P; Lui SF; Li PK; Sanderson JE
    Nephrol Dial Transplant; 2005 Aug; 20(8):1676-85. PubMed ID: 15899935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of AHSG gene polymorphisms and aortic stiffness in peritoneal dialysis patients.
    Jung JY; Hwang YH; Lee H; Ro H; Lee H; Chung W; Chae DW; Joo KW; Ahn C; Oh KH
    Am J Nephrol; 2010; 31(6):510-7. PubMed ID: 20453496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating fetuin-A predicts early mortality in chronic hemodialysis patients.
    Bláha V; Mistrík E; Dusilová-Sulková S; Kalousová M; Andrýs C; Bláha M; Sobotka L
    Clin Biochem; 2009 Jul; 42(10-11):996-1000. PubMed ID: 19341719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low serum fetuin-A concentration predicts poor outcome only in the presence of inflammation in prevalent haemodialysis patients.
    Metry G; Stenvinkel P; Qureshi AR; Carrero JJ; Yilmaz MI; Bárány P; Snaedal S; Heimbürger O; Lindholm B; Suliman ME
    Eur J Clin Invest; 2008 Nov; 38(11):804-11. PubMed ID: 19021697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment.
    Seiler S; Reichart B; Roth D; Seibert E; Fliser D; Heine GH
    Nephrol Dial Transplant; 2010 Dec; 25(12):3983-9. PubMed ID: 20525642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study.
    Ketteler M; Bongartz P; Westenfeld R; Wildberger JE; Mahnken AH; Böhm R; Metzger T; Wanner C; Jahnen-Dechent W; Floege J
    Lancet; 2003 Mar; 361(9360):827-33. PubMed ID: 12642050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum fetuin-A, cardiovascular risk factors, and six-year follow-up outcome in patients with coronary heart disease.
    Roos M; von Eynatten M; Heemann U; Rothenbacher D; Brenner H; Breitling LP
    Am J Cardiol; 2010 Jun; 105(12):1666-72. PubMed ID: 20538112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between fetuin-A concentration, elevated levels of inflammatory markers, and arterial wall stiffness in end-stage kidney disease.
    Kuźniar J; Porazko T; Klinger M
    J Ren Nutr; 2008 Jan; 18(1):83-6. PubMed ID: 18089450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomere attrition is associated with inflammation, low fetuin-A levels and high mortality in prevalent haemodialysis patients.
    Carrero JJ; Stenvinkel P; Fellström B; Qureshi AR; Lamb K; Heimbürger O; Bárány P; Radhakrishnan K; Lindholm B; Soveri I; Nordfors L; Shiels PG
    J Intern Med; 2008 Mar; 263(3):302-12. PubMed ID: 18070000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of low serum fetuin A levels with poor arteriovenous access patency in patients undergoing maintenance hemodialysis.
    Chen HY; Chiu YL; Chuang YF; Hsu SP; Pai MF; Lai CF; Yang JY; Peng YS; Tsai TJ; Wu KD
    Am J Kidney Dis; 2010 Oct; 56(4):720-7. PubMed ID: 20801568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D receptor gene, biochemical bone markers and bone mineral density in Mexican women on dialysis.
    Avila M; Prado C; Ventura MD; Mora C; Briones D; Valdez H; Hurtado ME; Lindholm B; Qureshi A; Castillo-Henkel C; Paniagua R
    Nephrol Dial Transplant; 2010 Jul; 25(7):2259-65. PubMed ID: 20124547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis.
    Hermans MM; Brandenburg V; Ketteler M; Kooman JP; van der Sande FM; Gladziwa U; Rensma PL; Bartelet K; Konings CJ; Hoeks AP; Floege J; Leunissen KM
    Nephrol Dial Transplant; 2006 May; 21(5):1293-9. PubMed ID: 16396973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the MTHFR C677T and A1298C polymorphisms on survival in patients with advanced CKD and ESRD: a prospective study.
    Jamison RL; Shih MC; Humphries DE; Guarino PD; Kaufman JS; Goldfarb DS; Warren SR; Gaziano JM; Lavori P;
    Am J Kidney Dis; 2009 May; 53(5):779-89. PubMed ID: 19272686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac calcifications: Fetuin-A and other risk factors in hemodialysis patients.
    Coen G; Manni M; Agnoli A; Balducci A; Dessi M; De Angelis S; Jankovic L; Mantella D; Morosetti M; Naticchia A; Nofroni I; Romagnoli A; Gallucci MT; Tomassini M; Simonetti G; Splendiani G
    ASAIO J; 2006; 52(2):150-6. PubMed ID: 16557100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.